<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04276805</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201902991</org_study_id>
    <nct_id>NCT04276805</nct_id>
  </id_info>
  <brief_title>Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults</brief_title>
  <official_title>Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>McKnight Brain Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      We need better tools to both enhance brain health and improve cognitive performance in
      healthy brain aging so that it can be delayed, reduced, or even reversed. The present
      proposal is designed to evaluate the pairing of cognitive training with a non-invasive
      neurostimulation technology that has shown promise in both increasing neuroplasticity and in
      enhancing cognitive performance, transcutaneous vagal nerve stimulation (tVNS).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in working memory and processing speed contributors</measure>
    <time_frame>Baseline to 2 weeks</time_frame>
    <description>The Posit Science BrainHQ</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>tVNS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will undergo cognitive training with tVNS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants will undergo cognitive training with earlobe sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous vagal nerve stimulation (tVNS)</intervention_name>
    <description>a non-invasive and safe technique that transiently enhances brain GABA and noradrenaline levels.</description>
    <arm_group_label>tVNS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive training</intervention_name>
    <description>A program of regular mental activities purported to maintain or improve one's cognitive abilities.</description>
    <arm_group_label>Sham group</arm_group_label>
    <arm_group_label>tVNS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy individuals willing to commit to study requirements

        Exclusion Criteria:

          -  Neurological disorders to include traumatic brain injury.

          -  Evidence of dementia .

          -  Major psychiatric illness

          -  Unstable and chronic medical conditions.

          -  MRI contraindications (e.g., pregnancy, claustrophobia, metal implants that are
             contraindicated for MRI).

          -  Physical impairment precluding motor response or lying still or walking

          -  Hearing or vision deficits that will not allow for completion of assessments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Williamson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Williamson, PhD</last_name>
    <phone>352-376-1611</phone>
    <phone_ext>6920</phone_ext>
    <email>john.williamson@ufl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85721</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2020</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

